Private Wealth Partners’s Pacific Biosciences PACB Stock Holding History

Private Wealth Partners’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$42K	Hold	25,000	–	–	﹤0.01%	183
2026 Q1	$33K	Hold	25,000	–	–	﹤0.01%	169
2025 Q4	$46.8K	Buy	+25,000	New	+$48K	﹤0.01%	169
2024 Q3	–	Sell	-40,000	Closed	-$54.8K	–	174
2024 Q2	$54.8K	Hold	40,000	–	–	﹤0.01%	165
2024 Q1	$150K	Buy	40,000 +30,000	+300%	+$176K	0.01%	160
2023 Q4	$98.1K	Buy	+10,000	New	+$81.8K	0.01%	170

Other funds holding PACB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Private Wealth Partners's PACB Position: Q2 2026 in Review

Private Wealth Partners held its Pacific Biosciences (PACB) position steady in Q2 2026 at 25,000 shares worth $42K. The position accounts for ﹤0.01% of the portfolio, ranked #183.

Private Wealth Partners first reported a position in PACB in Q4 2023 and has held it in 6 quarters since. The position peaked at $150K in Q1 2024. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

Private Wealth Partners held 25,000 shares of Pacific Biosciences worth $42K as of Q2 2026.
Private Wealth Partners left its Pacific Biosciences share count unchanged in Q2 2026.
Pacific Biosciences made up ﹤0.01% of Private Wealth Partners's portfolio in Q2 2026, its #183 holding.
Private Wealth Partners first reported a position in Pacific Biosciences in Q4 2023 and has held it in 6 quarters since.
Private Wealth Partners's Pacific Biosciences position peaked at $150K in Q1 2024.
223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on Private Wealth Partners's 13F filing for Q2 2026, filed 3 Aug 2026.